Macrophages at the fork in the road to health or disease.

PubWeight™: 0.82‹?›

🔗 View Article (PMC 4329822)

Published in Front Immunol on February 16, 2015

Authors

Charles D Mills1, Laurel L Lenz2, Klaus Ley3

Author Affiliations

1: BioMedical Consultants , Marine on St. Croix, MN , USA.
2: Department of Immunology and Microbiology, University of Colorado School of Medicine , Aurora, CO , USA.
3: La Jolla Institute for Allergy and Immunology , La Jolla, CA , USA.

Articles cited by this

Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 26.08

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med (1986) 17.64

Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol (2011) 12.21

Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol (2006) 9.82

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science (2011) 7.95

L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol (1987) 6.93

Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol (1991) 6.92

M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol (2000) 6.61

Arginine metabolism: nitric oxide and beyond. Biochem J (1998) 6.44

Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer (2006) 5.60

Tumor-associated macrophages: from mechanisms to therapy. Immunity (2014) 4.69

Tissue-specific signals control reversible program of localization and functional polarization of macrophages. Cell (2014) 2.61

M1 and M2 Macrophages: Oracles of Health and Disease. Crit Rev Immunol (2012) 2.49

Temporal expression of different pathways of 1-arginine metabolism in healing wounds. J Immunol (1990) 2.06

M1 and M2 macrophages: the chicken and the egg of immunity. J Innate Immun (2014) 2.06

From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation. Front Immunol (2014) 2.03

Molecular mechanisms that influence the macrophage m1-m2 polarization balance. Front Immunol (2014) 1.62

Macrophage arginine metabolism to ornithine/urea or nitric oxide/citrulline: a life or death issue. Crit Rev Immunol (2001) 1.61

Nitric oxide increases susceptibility of Toll-like receptor-activated macrophages to spreading Listeria monocytogenes. Immunity (2012) 1.55

Metabolic reprograming in macrophage polarization. Front Immunol (2014) 1.55

Regulation of macrophage functions by L-arginine. J Exp Med (1989) 1.49

Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy. Clin Dev Immunol (2011) 1.41

Macrophage arginine metabolism and the inhibition or stimulation of cancer. J Immunol (1992) 1.35

Species differences in macrophage NO production are important. Nat Immunol (2002) 1.24

Microenvironmental arginine depletion by macrophages in vivo. Br J Cancer (1979) 1.23

Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages. Front Immunol (2014) 1.15

Evolution of Innate Immunity: Clues from Invertebrates via Fish to Mammals. Front Immunol (2014) 1.13

Macrophages: supportive cells for tissue repair and regeneration. Immunobiology (2013) 1.10

Functional Relationship between Tumor-Associated Macrophages and Macrophage Colony-Stimulating Factor as Contributors to Cancer Progression. Front Immunol (2014) 1.07

Complement, c1q, and c1q-related molecules regulate macrophage polarization. Front Immunol (2014) 1.06

Ontogeny and polarization of macrophages in inflammation: blood monocytes versus tissue macrophages. Front Immunol (2015) 1.05

Dynamic Aspects of Macrophage Polarization during Atherosclerosis Progression and Regression. Front Immunol (2014) 1.04

Rethinking regenerative medicine: a macrophage-centered approach. Front Immunol (2014) 1.03

Macrophage polarization in obesity and type 2 diabetes: weighing down our understanding of macrophage function? Front Immunol (2014) 1.02

Myeloid colony-stimulating factors as regulators of macrophage polarization. Front Immunol (2014) 1.00

"Of mice and men": arginine metabolism in macrophages. Front Immunol (2014) 0.99

The ancestry and cumulative evolution of immune reactions. Acta Biochim Pol (2010) 0.98

Role of alveolar macrophages in chronic obstructive pulmonary disease. Front Immunol (2014) 0.96

Rationale for combined blockade of PD-1 and CTLA-4 in advanced head and neck squamous cell cancer—review of current data. Oral Oncol (2014) 0.96

Depletion of tumor-associated macrophages slows the growth of chemically induced mouse lung adenocarcinomas. Front Immunol (2014) 0.94

Macrophage: SHIP of Immunity. Front Immunol (2014) 0.92

Nitric oxide synthase: non-canonical expression patterns. Front Immunol (2014) 0.92

Evolutionary roots of arginase expression and regulation. Front Immunol (2014) 0.92

SOCS Proteins in Macrophage Polarization and Function. Front Immunol (2014) 0.88

Functions of arginase isoforms in macrophage inflammatory responses: impact on cardiovascular diseases and metabolic disorders. Front Immunol (2014) 0.87

Classical and Alternative Activation and Metalloproteinase Expression Occurs in Foam Cell Macrophages in Male and Female ApoE Null Mice in the Absence of T and B Lymphocytes. Front Immunol (2014) 0.86

Cholesterol efflux pathways regulate myelopoiesis: a potential link to altered macrophage function in atherosclerosis. Front Immunol (2014) 0.86

M1/M2 macrophage polarity in normal and complicated pregnancy. Front Immunol (2014) 0.85

Phenotypic diversity and emerging new tools to study macrophage activation in bacterial infectious diseases. Front Immunol (2014) 0.83

Regulation of Macrophage Polarization by RON Receptor Tyrosine Kinase Signaling. Front Immunol (2014) 0.82

Hepatic Localization of Macrophage Phenotypes during Fibrogenesis and Resolution of Fibrosis in Mice and Humans. Front Immunol (2014) 0.82

Purinergic and calcium signaling in macrophage function and plasticity. Front Immunol (2014) 0.81

Are "resting" microglia more "m2"? Front Immunol (2014) 0.80

Spatial, Temporal, and Functional Aspects of Macrophages during "The Good, the Bad, and the Ugly" Phases of Inflammation. Front Immunol (2014) 0.80

The role of myeloid cell activation and arginine metabolism in the pathogenesis of virus-induced diseases. Front Immunol (2014) 0.79

Articles by these authors

Macrophage: SHIP of Immunity. Front Immunol (2014) 0.92